Regulatory Toxicology and Pharmacology

Papers
(The H4-Index of Regulatory Toxicology and Pharmacology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
Systematic review of epidemiological studies evaluating the association between exposure to man-made vitreous fibers and non-malignant respiratory diseases142
Resource and animal use implications of the proposed REACH information requirements for endocrine disruptor assessment69
Butylated hydroxyanisole: Carcinogenic food additive to be avoided or harmless antioxidant important to protect food supply?67
The need for guidance in antidepressant drug development: Revisiting the role of the forced swim test and tail suspension test62
Two-year carcinogenicity study of a novel plasticizer, bis(2-ethylhexyl) cyclohexane-1,4-dicarboxylate (Eco-DEHCH), by oral diet in Han Wistar rats55
Preclinical screening for antidepressant activity – shifting focus away from the Forced Swim Test to the use of translational biomarkers52
Comprehensive analysis of chronic rodent inhalation toxicity studies for methyl acrylate with attention to test conditions exceeding a maximum tolerated concentration50
Sensory irritation and use of the best available science in setting exposure limits: Issues raised by a scientific panel review of formaldehyde human research studies50
28-Day oral (gavage) and 13-week (dietary) toxicity studies of DHA canola oil and DHA canola meal in rats45
Quantitative risk assessment of skin sensitising pesticides: Clinical and toxicological considerations41
Preclinical safety, toxicokinetics and metabolism of BIIB131, a novel prothrombolytic agent for acute stroke40
Letter to the editors regarding “The conundrum of the PFOA human half-life, an international collaboration”33
Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acids33
Editorial Board31
Formation and evaluation of mechanism-based chemical categories for regulatory read-across assessment of repeated-dose toxicity: A case of hemolytic anemia30
Inhalation exposure assessments under REACH – Problems encountered using the approach recommended by the ECHA guidance R.1529
Editorial Board27
Proposal for regulatory risk mitigation measures for human pharmaceutical residues in the environment26
Controlling cleaning agent residues in pharmaceutical manufacturing: A harmonized scientific strategy26
Probabilistic methods for non-cancer health effects26
Use of nonclinical toxicity studies to support biosimilar antibody development25
Pathogenetic role of alveolar surfactant depleted by phosgene: Biophysical mechanisms and peak inhalation exposure metrics25
Perspectives on the elimination of animal assays in the assessment of carcinogenicity25
Editorial Board25
Ability of mathematical models to predict human in vivo percutaneous penetration of steroids25
0.044456005096436